BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa

Oct 03, 2023

Posted by BioIVT

ERP for Cell & Gene Therapy Firms

Sep 27, 2023

Posted by Navigator Business Solutions

Sr. Project Lead

Sep 25, 2023

Posted by Novo Nordisk A/S

Laminar Pharma Receives Rare Pediatric Disease Designation from the U.S. FDA for LAM561

Sep 22, 2023

Annual reminder: Medicare Part D (Creditable Coverage) Notices due to individuals

Sep 21, 2023

Posted by Marsh McLennan Agency